RYDAPT

What this means for you

Registered since 31 Mar 2015. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79149774

Registration number

4710118

Mark type

Stylized text

Filed

04 Jun 2014

Published for opposition

13 Jan 2015

Registered

31 Mar 2015

Attorney of record

Maury M. Tepper, III

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular and metabolic system including diabetes, the respiratory system, the genitourinary system, for musculo-skeletal and inflammatory disorders, or for use in dermatology,] oncology, hematology [, ophthalmology, and in transplantation; pharmaceutical preparations for use in gastroenterology, for the prevention and treatment of ocular disorders; anti-infective preparations, antibiotics, antibacterial, antiviral and anti-fungal preparations, vaccines, pharmaceutical preparations for diagnostic use for medical purposes]

Owner

• Novartis AG, Basel, CH
• Novartis AG, CH
• Novartis AG, CH

Prior registrations

• Registration 3441082

Prosecution history

• 23 Feb 2026 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
• 23 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
• 23 Jun 2025 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
• 18 Jun 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 10 Mar 2025 — TEAS SECTION 71 & 15 RECEIVED
• 31 Mar 2024 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
• 09 Jun 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
• 09 Jun 2021 — REGISTERED-SEC.71 ACCEPTED
• 21 Jan 2021 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 11 Nov 2020 — TEAS SECTION 71 RECEIVED
• 31 Mar 2020 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
• 14 Sept 2017 — INTERNATIONAL REGISTRATION RENEWED
• 17 Oct 2015 — FINAL DECISION TRANSACTION PROCESSED BY IB
• 16 Oct 2015 — TOTAL INVALIDATION PROCESSED BY THE IB
• 31 Jul 2015 — FINAL DISPOSITION NOTICE SENT TO IB